Second, in terms of the literature report and preliminary experiment of irisin concentration gradient, we only confirm 250 μg kg−1 per week as the effective injection dose in PAH mice, however, the optimal therapeutic dose of irisin in patients with PAH remains unknown and needs to be further investigated. This evidence concerns the gene FNDC5 and pulmonary arterial hypertension.